References
- Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L et al. (2002). Cardiac resynchronization in chronic heart failure. New Engl. J. Med., 346 (24), 1845–1853.10.1056/NEJMoa01316812063368
- Barra, S., Providźncia, R., Agarwal, S., Marijon, E., Boveda, S. (2017). The benefit of cardiac resynchronization therapy is not hindered by the number of comorbidities. J. Amer. Coll. Cardiol., 70 (16), 2096–2097.10.1016/j.jacc.2017.06.07729025565
- Brignole, M., Auricchio, A., Baron-Esquivias, G., Bordachar, P., Boriani, G, Breithardt, O. A., Cleland, J., Deharo, J. C, Delgado, V., Elliott, P. M. et al. (2013). 2013 ESC Guidelines on cardiac pacing and cardiacre-synchronization therapy. Eur. Heart J.,34, 2281–2329.
- Cazeau, S., Leclercq, C., Lavergne, T., Walker, S., Varma, C., Linde, C., Garrigue, S., Kappenberger, L., Haywood, G. A., Santini, M., Bailleul, C., Daubert, J. C., Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators (2001). Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. New Engl. J. Med.,344 (12), 873–880.10.1056/NEJM20010322344120211259720
- Chung, E. S., Katra, R. P., Ghio, S., Bax, J., Gerritse, B., Hilpisch, K., Peterson, B. J., Feldman, D. S., Abraham, W. T. (2010). Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction 35%: a PROSPECT trial substudy. Eur. J. Heart Failure,12 (6), 581–587.10.1093/eurjhf/hfq00920150328
- Cleland, J. G. F., Daubert, J.-C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., Tavazzi, L. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New Engl. J. Med., 352, 1539–1549.10.1056/NEJMoa05049615753115
- Cullington, D., Goode, K. M., Clark, A. L., Cleland, J. G. (2012), Heart rate achieved or beta-blocker dose in patients with chronic heart failure: Which is the better target? Eur. J. Heart Failure, 14, 737–747.10.1093/eurjhf/hfs06022622001
- Dickstein, K., Bogale, N., Priori, S., Auricchio, A., Cleland, J. G., Gitt, A., Limbourg, T., Linde, C., van Veldhuisen, D. J., Brugada, J., Scientific Committee, National Coordinators (2009). The European cardiac resynchronization therapy survey. Eur. Heart J.,30 (20), 2450–2460.10.1093/eurheartj/ehp35919723694
- Dickstein, K., Normand, C., Anker, S. D., Auricchio, A., Blomström-Lundqvist, C., Bogale, N., Cleland, J., Filippatos, G., Gasparini, M., Gitt, A., Hindricks, G., Kuck, K.H., Ponikowski, P., Stellbrink, C., Ruschitzka, F., Linde, C. (2015). European Cardiac Resynchronization Therapy Survey II: rationale and design. EP Europace, 17 (1), 137–141.10.1093/europace/euu31225414481
- Dickstein, K., Normand, C., Auricchio, A., Bogale, N., Cleland, J. G., Gitt, A. K., Stellbrink, C., Anker, S. D., Filippatos, G., Gasparini, M. et al. (2018). CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients — who is doing what to whom and how? Eur. J. Heart Failure, 20, 1039–1051.10.1002/ejhf.114229457358
- Farwell, D., Patel, N. R., Hall, A., Ralph, S., Sulke, A. N. (2000). How many people with heart failure are appropriate for biventricular resynchronization? Eur. Heart J.,21 (15), 1246–1250.10.1053/euhj.1999.198510924314
- Gurevitz, O., Nof, E., Carasso, S., Luria, D., Bar-Lev, D., Tanami, N., Eldar, M., Glikson, M. (2005). Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation. Pacing Clin. Electrophysiol., PACE, 28 (12), 1255–1259.10.1111/j.1540-8159.2005.00265.x
- Hayes, D. L., Boehmer, J. P., Day, J. D., Gilliam, F. R., 3rd, Heidenreich, P. A., Seth, M., Jones, P. W., Saxon, L. A. (2011). Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm, 8 (9), 1469–1475.10.1016/j.hrthm.2011.04.015
- Linde, C., Curtis, A. B., Fonarow, G. C., Lee, K., Little, W., Tang, A., Levya, F., Momomura, S., Manrodt, C., Bergemann, T., Cowie, M. R. (2016). Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study. Int. J. Cardiol.,202, 349–355.10.1016/j.ijcard.2015.09.023
- Maggioni, A.P., Anker, S.D., Dahlström, U., Filippatos, G., Ponikowski, P., Zannad, F., Amir, O., Chioncel, O., Leiro, M.C., Drozdz, J., Erglis, A. et al. (2013). Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry. Eur. J. Heart Failure, 15, 1173–1184.10.1093/eurjhf/hft134
- Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N. A. 3rd, Foster, E., Greenberg, H., Higgins, S. L., Pfeffer, M. A., Solomon, S. D., Wilber, D., Zareba, W. (2009). Cardiac-resynchronization therapy for the prevention of heart-failure events. New Engl. J. Med.,361, 1329–1338.10.1056/NEJMoa0906431
- Ni, H., Xu, J. (2015). Recent trends in heart failure-related mortality: United States, 2000–2014. NCHS data brief, (231), 1–8.
- Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. H., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V. P., Jankowska, E. A. et al. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. J. Heart Failure, 18 (8), 891–975.10.1002/ejhf.592
- Savarese, G., Lund, L. H. (2017). Global public health burden of heart failure. Cardiac Failure Rev., 3 (1), 7–11.10.15420/cfr.2016:25:2
- Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., Tavazzi, L., SHIFT Investigators (2010). Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study. Lancet,376 (9744), 875–885.10.1016/S0140-6736(10)61198-1
- Swedberg, K., Komajda, M., Böhm, M., Borer, J., Robertson, M., Tavazzi, L., Ford, I., SHIFT Investigators (2012). Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: Is there an influence of beta-blocker dose? J. Amer. Coll. Cardiol.,59 (22), 1938–1945.10.1016/j.jacc.2012.01.020
- Witt, C. M., Wu, G., Yang, D., Hodge, D. O., Roger, V. L., Cha, Y. M. (2016). Outcomes with left bundle branch block and mildly to moderately reduced left ventricular function. JACC. Heart Failure, 4 (11), 897–903.10.1016/j.jchf.2016.07.00227614941
- Zeitler, E. P., Friedman, D. J., Daubert, J. P., Al-Khatib, S. M., Solomon, S. D., Biton, Y., McNitt, S., Zareba, W., Moss, A. J., Kutyifa, V. (2017). Multiple comorbidities and response to cardiac resynchronization therapy: MADIT-CRT long-term follow-up. J. Amer. Coll.Cardiol.,69 (19), 2369–2379.10.1016/j.jacc.2017.03.531649947928494974